Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ-Reference-Cited by-同舟云学术

Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ

Published:2020-08-19 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Farolfi Alberto,Petracci Elisabetta,Serra Luigi,Ravaioli Alessandra,Bravaccini Sara,Ravaioli Sara,Tumedei Maria Maddalena,Ulivi Paola,Canale Matteo,Puccetti Maurizio,Falcini Fabio,Folli Secondo,Curcio Annalisa,Rocca Andrea

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference30 articles.

1. Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation;Pinder;Mod Pathol,2010

2. The benefits and harms of breast cancer screening: an independent review;Lancet,2012

3. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study;Duffy;Lancet Oncol,2016

4. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK sloane project;Thompson;Eur J Cancer,2018

5. Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: who to treat more and who to treat less;Toss;Breast,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast;Breast Cancer Research and Treatment;2024-08-24

2. The Biology and Management of Ductal Carcinoma in Situ of the Breast;Current Problems in Surgery;2023-08

3. Identifying recurrences and metastasis after ductal carcinoma in situ ( DCIS ) of the breast;Histopathology;2022-12-08

4. Learning to distinguish progressive and non-progressive ductal carcinoma in situ;Nature Reviews Cancer;2022-10-19

5. Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast;Cancers;2022-08-13